Telomir Pharmaceuticals
TELO | NASDAQ
$0.49
-$0.01 (-2.08%)
At close: Nov 13, 2026, 4:00 PM ET
$0.50
+$0.01 (+2.45%)
After-hours:
Nov 13, 2026, 7:30 PM ET
Telomir Pharmaceuticals Company Profile
Company profile explainedCompany Profile
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.
Key Executives
| Name | Position |
|---|---|
| Erez Aminov | Chairman of the Board & Chief Executive Officer |
| Andriy Mushak | Chief Financial Officer |
| Itzchak Angel | Chief Scientific Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | S-3 | Filing |
| Oct 06, 2026 | 8-K | Current Report |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 8-K | Current Report |
| Sep 14, 2026 | 8-K | Current Report |
| Aug 19, 2026 | DEFA14A | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 10, 2026 | 8-K | Current Report |
| Jul 28, 2026 | DEF 14A | Filing |
Telomir Pharmaceuticals
| Country | United States |
| IPO Date | Feb 9, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Erez Aminov |
Contact Details
100 SE 2nd Street Miami,
Florida 33131 United States
Stock Details
| Ticker Symbol | TELO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001971532 |
| CUSIP Number | 87975F104 |
| ISIN Number | US87975F1049 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove TELO